-
Something wrong with this record ?
Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids
P. Flachs, R. Rühl, M. Hensler, P. Janovska, P. Zouhar, V. Kus, Z. Macek Jilkova, E. Papp, O. Kuda, M. Svobodova, M. Rossmeisl, G. Tsenov, V. Mohamed-Ali, J. Kopecky
Language English Country Germany
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
SpringerLink Journals
from 1997-01-01 to 2012-08-31
ProQuest Central
from 1999-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1999-01-01 to 1 year ago
Public Health Database (ProQuest)
from 1999-01-01 to 1 year ago
- MeSH
- Adipose Tissue, White drug effects metabolism MeSH
- Diet, High-Fat MeSH
- Dietary Fats pharmacology MeSH
- Energy Metabolism drug effects MeSH
- Immunohistochemistry MeSH
- Caloric Restriction MeSH
- Real-Time Polymerase Chain Reaction MeSH
- Docosahexaenoic Acids metabolism MeSH
- Fatty Acids, Omega-3 pharmacology MeSH
- Lipid Metabolism drug effects MeSH
- Mice, Obese MeSH
- Mice MeSH
- Prostaglandin D2 analogs & derivatives metabolism MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
AIMS/HYPOTHESIS: Calorie restriction is an essential component in the treatment of obesity and associated diseases. Long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFA) act as natural hypolipidaemics, reduce the risk of cardiovascular disease and could prevent the development of obesity and insulin resistance. We aimed to characterise the effectiveness and underlying mechanisms of the combination treatment with LC n-3 PUFA and 10% calorie restriction in the prevention of obesity and associated disorders in mice. METHODS: Male mice (C57BL/6J) were habituated to a corn-oil-based high-fat diet (cHF) for 2 weeks and then randomly assigned to various dietary treatments for 5 weeks or 15 weeks: (1) cHF, ad libitum; (2) cHF with LC n-3 PUFA concentrate replacing 15% (wt/wt) of dietary lipids (cHF + F), ad libitum; (3) cHF with calorie restriction (CR; cHF + CR); and (4) cHF + F + CR. Mice fed a chow diet were also studied. RESULTS: We show that white adipose tissue plays an active role in the amelioration of obesity and the improvement of glucose homeostasis by combining LC n-3 PUFA intake and calorie restriction in cHF-fed mice. Specifically in the epididymal fat in the abdomen, but not in other fat depots, synergistic induction of mitochondrial oxidative capacity and lipid catabolism was observed, resulting in increased oxidation of metabolic fuels in the absence of mitochondrial uncoupling, while low-grade inflammation was suppressed, reflecting changes in tissue levels of anti-inflammatory lipid mediators, namely 15-deoxy-Δ(12,15)-prostaglandin J(2) and protectin D1. CONCLUSIONS/INTERPRETATION: White adipose tissue metabolism linked to its inflammatory status in obesity could be modulated by combination treatment using calorie restriction and dietary LC n-3 PUFA to improve therapeutic strategies for metabolic syndrome.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12024411
- 003
- CZ-PrNML
- 005
- 20130417152050.0
- 007
- ta
- 008
- 120815e20110721gw f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00125-011-2233-2 $2 doi
- 035 __
- $a (PubMed)21779874
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Flachs, Pavel. $7 _AN029338 $u Department of Adipose Tissue Biology, Institute of Physiology Academy of Sciences of the Czech Republic v.v.i., Videnska 1083, 14220 Prague, Czech Republic.
- 245 10
- $a Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids / $c P. Flachs, R. Rühl, M. Hensler, P. Janovska, P. Zouhar, V. Kus, Z. Macek Jilkova, E. Papp, O. Kuda, M. Svobodova, M. Rossmeisl, G. Tsenov, V. Mohamed-Ali, J. Kopecky
- 520 9_
- $a AIMS/HYPOTHESIS: Calorie restriction is an essential component in the treatment of obesity and associated diseases. Long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFA) act as natural hypolipidaemics, reduce the risk of cardiovascular disease and could prevent the development of obesity and insulin resistance. We aimed to characterise the effectiveness and underlying mechanisms of the combination treatment with LC n-3 PUFA and 10% calorie restriction in the prevention of obesity and associated disorders in mice. METHODS: Male mice (C57BL/6J) were habituated to a corn-oil-based high-fat diet (cHF) for 2 weeks and then randomly assigned to various dietary treatments for 5 weeks or 15 weeks: (1) cHF, ad libitum; (2) cHF with LC n-3 PUFA concentrate replacing 15% (wt/wt) of dietary lipids (cHF + F), ad libitum; (3) cHF with calorie restriction (CR; cHF + CR); and (4) cHF + F + CR. Mice fed a chow diet were also studied. RESULTS: We show that white adipose tissue plays an active role in the amelioration of obesity and the improvement of glucose homeostasis by combining LC n-3 PUFA intake and calorie restriction in cHF-fed mice. Specifically in the epididymal fat in the abdomen, but not in other fat depots, synergistic induction of mitochondrial oxidative capacity and lipid catabolism was observed, resulting in increased oxidation of metabolic fuels in the absence of mitochondrial uncoupling, while low-grade inflammation was suppressed, reflecting changes in tissue levels of anti-inflammatory lipid mediators, namely 15-deoxy-Δ(12,15)-prostaglandin J(2) and protectin D1. CONCLUSIONS/INTERPRETATION: White adipose tissue metabolism linked to its inflammatory status in obesity could be modulated by combination treatment using calorie restriction and dietary LC n-3 PUFA to improve therapeutic strategies for metabolic syndrome.
- 650 _2
- $a bílá tuková tkáň $x účinky léků $x metabolismus $7 D052436
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kalorická restrikce $7 D031204
- 650 _2
- $a dieta s vysokým obsahem tuků $7 D059305
- 650 _2
- $a dietní tuky $x farmakologie $7 D004041
- 650 _2
- $a kyseliny dokosahexaenové $x metabolismus $7 D004281
- 650 _2
- $a energetický metabolismus $x účinky léků $7 D004734
- 650 _2
- $a kyseliny mastné omega-3 $x farmakologie $7 D015525
- 650 _2
- $a imunohistochemie $7 D007150
- 650 _2
- $a metabolismus lipidů $x účinky léků $7 D050356
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši obézní $7 D008820
- 650 _2
- $a prostaglandin D2 $x analogy a deriváty $x metabolismus $7 D015230
- 650 _2
- $a kvantitativní polymerázová řetězová reakce $7 D060888
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Rühl, R
- 700 1_
- $a Hensler, M
- 700 1_
- $a Janovská, P
- 700 1_
- $a Zouhar, P
- 700 1#
- $a Kůs, Vladimír. $7 _AN042416
- 700 1_
- $a Macek Jílková, Zuzana, $d 1981- $7 xx0128795
- 700 1_
- $a Papp, E
- 700 1_
- $a Kuda, Ondřej $7 jx20070820013
- 700 1_
- $a Svobodová, M.
- 700 1_
- $a Rossmeisl, M
- 700 1_
- $a Tsenov, G
- 700 1_
- $a Mohamed-Ali, V
- 700 1_
- $a Kopecky, J
- 773 0_
- $w MED00001391 $t Diabetologia $x 1432-0428 $g Roč. 54, č. 10 (20110721), s. 2626-38
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21779874 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120815 $b ABA008
- 991 __
- $a 20130417152329 $b ABA008
- 999 __
- $a ok $b bmc $g 946559 $s 781739
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 54 $c 10 $d 2626-38 $e 20110721 $i 1432-0428 $m Diabetologia (Berlin) $n Diabetologia $x MED00001391
- LZP __
- $a Pubmed-20120815/12/02